Odense University Hospital
Odense C, 5000, Denmark
NCT Number: NCT01742923
Patients with hypertension have an increased risk of stroke and myocardial infarction. However, poor adherence to treatment with antihypertensives and lipid-lowering agents occurs frequently within this patient group. The purpose of this study is to investigate whether a complex tailored intervention in a hospital setting will lead to increased medication adherence and fewer cardiovascular events when compared to a usual care group. Interventions focus on motivational interviewing, medication review and telephone follow up.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Odense C, 5000, Denmark
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Age: 18 years or older
Exclusion criteria
Time frame: One year from inclusion
Time frame: One year from inclusion
Time frame: One year from inclusion
Time frame: One year from inclusion
Odense University Hospital
Other
Pharmacist Intervention Programme in Secondary Care to Improve Medication Adherence in Patients With Hypertension
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05610059
Aging, Behavior
Tucson, Arizona, United States
View Trial DetailsNCT04675593
Behavior, Bipolar Disorder
Cleveland, Ohio, United States
View Trial DetailsNCT05308914
Behavior, Cardiovascular Diseases
Cleveland, Ohio, United States
View Trial DetailsNCT04708756
Behavior, Cardiovascular Diseases
Basel, Switzerland
View Trial Details